Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 20,110 | 15,606 | 11,752 | 27,765 | 36,245 |
| TOTAL | $20,110 | $15,606 | $11,752 | $27,765 | $36,245 |
| Non-Current Assets | |||||
| PPE Net | 262,977 | 257,309 | 250,940 | 246,218 | 239,422 |
| Investments And Advances | 13,631 | 11,107 | 10,732 | 9,901 | 9,548 |
| Other Non-Current Assets | 36,676 | 36,827 | 36,957 | 36,791 | 35,543 |
| TOTAL | $313,284 | $305,243 | $298,629 | $292,910 | $284,513 |
| Total Assets | $333,394 | $320,849 | $310,381 | $320,675 | $320,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,776 | 14,720 | 9,087 | 29,679 | 38,721 |
| Accounts payable and accrued liabilities | 18,448 | 14,064 | 17,019 | 12,149 | 19,945 |
| Accrued Expenses | 5,823 | 4,315 | 3,906 | 4,116 | 5,688 |
| TOTAL | $57,637 | $43,452 | $42,719 | $69,051 | $92,898 |
| Non-Current Liabilities | |||||
| TOTAL | $65,584 | $64,500 | $63,800 | $62,934 | $61,671 |
| Total Liabilities | $123,221 | $107,952 | $106,519 | $131,985 | $154,569 |
| Shareholders' Equity | |||||
| Common Shares | 48,721 | 48,428 | 48,307 | 48,157 | 48,040 |
| TOTAL | $71,810 | $70,293 | $69,643 | $68,927 | $68,431 |
| Total Liabilities And Equity | $195,031 | $178,245 | $176,162 | $200,912 | $223,000 |